Back to search
Hand, Foot, and Mouth Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hand, Foot, and Mouth Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Hand, Foot, and Mouth Disease trials you may qualify forThis is a multicenter clinical trial investigating the safety and efficacy of inhaled Peginterferon α-2b at different doses, in combination with supportive care…
This multicenter, randomized, double-blind, controlled Phase III clinical trial aims to evaluate the efficacy, safety, and immunogenicity of the bivalent entero…
Background: China's healthcare system for children faces significant challenges, particularly due to the limited pediatric service capacity of primary healthcar…
The aims of this prospective multicentric study is to determine the types of enteroviruses (EVs) responsible for hand, foot and mouth disease (HFMD) or herpangi…
This study is a randomized, blinded study to evaluate the lot-to-lot consistency of immunogenicity, safety, and immune persistence of three consecutive manufact…
The trial aims to assess the tolerability, safety, and immunogenicity of the tetravalent inactivated enterovirus vaccine in adults and children aged 6 months to…
The Phase I clinical trial is divided into two parts. The first part uses an open-label design, while the second part uses a randomized, double-blind, and contr…